Skip to main content

ImaGenes to Distribute Invitrogen Clones in Europe

NEW YORK (GenomeWeb News) – Invitrogen has signed up ImaGenes as a distributor for its Gateway ORF clones in Europe, ImaGenes said.
 
The Gateway system is used in restriction-free cloning and protein expression. ImaGenes said it plans to distribute the clones through its web-based clone portal, called GenomeCube.
 
The Berlin-based company is a spin-off of RZPD German Resource Center for Genome Research, a former Invitrogen distributor, and through a tri-lateral agreement ImaGenes has taken over the European distribution rights from RZPD. The center shut down in July 2007 and transferred its services operations to ImaGenes and Atlas Biolabs.
 
Financial terms of the agreement were not released.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.